Salimi A et al. |
Toxicity of macrolide antibiotics on isolated heart mitochondria: a justification for their cardiotoxic adverse effect. |
2016 |
Xenobiotica |
pmid:26068526
|
Liou JM et al. |
Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial. |
2016 |
Lancet |
pmid:27769562
|
Campillo A et al. |
[10-day triple therapy with esomeprazole 40 mg/12 h vs. quadruple concomitant non-bismuth therapy as first line treatment for Helicobacter pylori infection]. |
2016 |
Gastroenterol Hepatol |
pmid:27084668
|
Morimoto K et al. |
Macrolide-Resistant Mycobacterium avium Complex Lung Disease: Analysis of 102 Consecutive Cases. |
2016 |
Ann Am Thorac Soc |
pmid:27513168
|
Christianson S et al. |
Time-to-Detection of Inducible Macrolide Resistance in Mycobacterium abscessus Subspecies and Its Association with the Erm(41) Sequevar. |
2016 |
PLoS ONE |
pmid:27490181
|
Okano Y et al. |
Miliary pulmonary nodules due to Mycobacterium xenopi in a steroid-induced immunocompromised patient successfully treated with chemotherapy: a case report. |
2016 |
BMC Pulm Med |
pmid:27287608
|
Steurer J |
[Months of antibiotic therapy in persistent symptoms of Lyme disease without effect]. |
2016 |
Praxis (Bern 1994) |
pmid:27269781
|
Chung JW et al. |
Ten-day empirical sequential or concomitant therapy is more effective than triple therapy for Helicobacter pylori eradication: A multicenter, prospective study. |
2016 |
Dig Liver Dis |
pmid:27257049
|
Parize P et al. |
Induction therapy with linezolid/clarithromycin combination for Mycobacterium chelonae skin infections in immunocompromised hosts. |
2016 |
J Eur Acad Dermatol Venereol |
pmid:25677464
|
EmiralioÄŸlu N et al. |
Pulmonary Mycobacterium abscessus Infection in a Patient with Triple A Syndrome. |
2016 |
J. Trop. Pediatr. |
pmid:27080471
|
Graham DY and Dore MP |
Helicobacter pylori therapy: a paradigm shift. |
2016 |
Expert Rev Anti Infect Ther |
pmid:27077447
|
Song ZQ et al. |
Hybrid Therapy Regimen for Helicobacter Pylori Eradication. |
2016 |
Chin. Med. J. |
pmid:27064046
|
Meng X et al. |
[Antibiotic resistance of Helicobacter pylori clinical isolates in Hebei Province]. |
2016 |
Zhonghua Yi Xue Za Zhi |
pmid:26879786
|
Bakshi SS |
Outcome evaluation of clarithromycin, metronidazole and lansoprazole regimens in Helicobacter pylori positive or negative children with resistant otitis media with effusion. |
2016 |
J Laryngol Otol |
pmid:26878377
|
Franceschi F et al. |
High dose amoxicillin-based first line regimen is equivalent to sequential therapy in the eradication of H. pylori infection. |
2016 |
Eur Rev Med Pharmacol Sci |
pmid:26875899
|
Thung I et al. |
Review article: the global emergence of Helicobacter pylori antibiotic resistance. |
2016 |
Aliment. Pharmacol. Ther. |
pmid:26694080
|
Kamiya K et al. |
Erythema multiforme caused by triple therapy with amoxicillin, clarithromycin and vonoprazan for Helicobacter pylori. |
2016 |
J. Dermatol. |
pmid:26508502
|
Mark TM and Coleman M |
It's Time to Take Clarithromycin Seriously in Multiple Myeloma. |
2016 |
Acta Haematol. |
pmid:26505907
|
Lee J et al. |
A new anti-microbial combination prolongs the latency period, reduces acute histologic chorioamnionitis as well as funisitis, and improves neonatal outcomes in preterm PROM. |
2016 |
J. Matern. Fetal. Neonatal. Med. |
pmid:26373262
|
Tsujimae M et al. |
A Comparative Study of a New Class of Gastric Acid Suppressant Agent Named Vonoparazan versus Esomeprazole for the Eradication of Helicobacter pylori. |
2016 |
Digestion |
pmid:28030862
|